Literature DB >> 25959980

Hemispheric differences in malignant middle cerebral artery stroke.

Vaibhav Rastogi1, Damon G Lamb2, John B Williamson2, Thor S Stead1, Rachel Penumudi1, Sharathchandra Bidari3, Latha Ganti4, Kenneth M Heilman2, Vishnumurthy S Hedna5.   

Abstract

BACKGROUND: We recently reported that left versus right hemisphere cerebral infarctions patients more frequently have worse outcomes. However our clinical experience led us to suspect that the incidence of malignant middle cerebral artery infarctions (MMCA) was higher in the right compared to the left hemispheric strokes.
OBJECTIVE: To determine whether laterality in MMCA stroke is an important determinant of stroke sequelae.
METHODS: A systematic search was performed for publications in PubMed using "malignant middle cerebral artery and infarction". A total of 73 relevant studies were abstracted.
RESULTS: MMCA laterality data were available for 2673 patients, with 1687 (63%) right hemispheric involvement, thus right being more commonly associated with MMCA (binomial test, p<0.05). While mortality rates were similar, right hemispheric MMCA (n=271) had mortality of 31% (n=85) whereas left hemispheric MMCA (n=144) had mortality of 36% (n=53), morbidity rates were worse on the right.
CONCLUSION: MMCA stroke appears to be more common on the right, and this laterality is also associated with significantly higher morbidity. Further prospective studies are needed to more completely understand the nature of this laterality as well as test possible new treatments to reduce mortality and morbidity associated with MMCA.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic dysfunction; Decompressive hemicraniectomy; Insula; Laterality; Malignant middle cerebral artery stroke; Norepinephrine

Mesh:

Year:  2015        PMID: 25959980     DOI: 10.1016/j.jns.2015.04.036

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Outcome following surgical treatment of chronic subdural hematoma in the oldest-old population.

Authors:  Christopher Munoz-Bendix; Robert Pannewitz; Daniel Remmel; Hans-Jakob Steiger; Bernd Turowski; Phillip Jorg Slotty; Marcel Alexander Kamp
Journal:  Neurosurg Rev       Date:  2016-12-28       Impact factor: 3.042

2.  (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.

Authors:  Wan Li; Huihui Liu; Hanjie Jiang; Chen Wang; Yongfei Guo; Yi Sun; Xin Zhao; Xin Xiong; Xianhua Zhang; Ke Zhang; Zongxiu Nie; Xiaoping Pu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

3.  Relationship between normalized distributional pattern and functional outcome in patients with acute cardiogenic cerebral embolism.

Authors:  Masatoshi Takagaki; Manabu Kinoshita; Atsushi Kawaguchi; Akira Murasawa; Kazutami Nakao; Hajime Nakamura; Haruhiko Kishima
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

4.  MicroRNA Analysis of Human Stroke Brain Tissue Resected during Decompressive Craniectomy/Stroke-Ectomy Surgery.

Authors:  Andrew P Carlson; William McKay; Jeremy S Edwards; Radha Swaminathan; Karen S SantaCruz; Ron L Mims; Howard Yonas; Tamara Roitbak
Journal:  Genes (Basel)       Date:  2021-11-23       Impact factor: 4.096

5.  Stroke Lateralization in Large Hemisphere Infarctions: Characteristics, Stroke-Related Complications, and Outcomes.

Authors:  Jie Li; Ping Zhang; Yingying Liu; Wanli Chen; Xingyang Yi; Chun Wang
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.